Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Edward, Spangenthal"'
Autor:
Nikhil Agrawal, Arjun Khunger, Pankit Vachhani, Teresa A. Colvin, Alexander Hattoum, Edward Spangenthal, Anne B. Curtis, Grace K. Dy, Marc S. Ernstoff, Igor Puzanov
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptom
Externí odkaz:
https://doaj.org/article/050b36a63cac4605ad2f222a88150cca
Autor:
Pankit Vachhani, Alexander Hattoum, Arjun Khunger, Teresa A. Colvin, Marc S. Ernstoff, Grace K Dy, Nikhil Agrawal, Edward Spangenthal, Igor Puzanov, Anne B. Curtis
Publikováno v:
Case Reports in Oncology
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
Case Reports in Oncology, Vol 12, Iss 1, Pp 260-276 (2019)
The development of immune checkpoint inhibitors (ICIs) has revolutionized the treatment of patients with advanced stage cancers. However, immune-related adverse events are frequently observed. Cardiac toxicity from ICI therapy can range from asymptom
Autor:
Pankit Vachhani, Yan Yatsynovich, Igor Puzanov, Umesh C. Sharma, Edward Spangenthal, Arjun Khunger, Ankita Kapoor, Anne B. Curtis, Maya R. Chilbert, Nikhil Agrawal, Schentag J Jerome, Filip Stefanovic, Benjamin Switzer, Poornima Subramanian, Grace K. Dy, David M. Jacobs, Mark D. Hicar, Alexander Hattoum, Fumito Ito, Marc S. Ernstoff, Steven Feuerstein, Brian J Page
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 6 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
BackgroundImmune checkpoint inhibitors (ICI) have emerged as a front-line therapy for a variety of solid tumors. With the widespread use of these agents, immune-associated toxicities are increasingly being recognized, including fatal myocarditis. The
Autor:
Edward Spangenthal, Pankit Vachhani, Sarah Shin, Meir Wetzler, Jeffrey Baron, Eunice S. Wang, James E. Thompson, Evelena P. Ontiveros, Elizabeth A. Griffiths
Publikováno v:
Leukemia Research Reports, Vol 7, Iss C, Pp 36-39 (2017)
Leukemia Research Reports
Leukemia Research Reports
Anthracyclines constitute the backbone of intensive adult acute myeloid leukemia (AML) therapy. Cardiotoxicity is one of its most serious adverse effects, and its incidence increases with cumulative dose. Dexrazoxane is a cardioprotective agent used
Autor:
Venkata K. Pokuri, Saby George, Marcus Sikorski, Laurie Herbst, Houman Nourkeyhani, Andrew J. Fabiano, Bodie Betsy, Edward Spangenthal
Publikováno v:
Journal of the National Comprehensive Cancer Network. 13:e49-e55
The testosterone surge and disease flare is a feared complication from initiation of gonadotropin-releasing hormone (GnRH) agonist treatment in advanced prostate adenocarcinoma. It is a common practice to start an average 7-day pretreatment regimen w
Publikováno v:
BMJ Case Rep
An 84-year-old man with a history of deep vein thrombosis on warfarin and coronary artery disease presented with haematochezia and was diagnosed with an ascending colon cancer. He was short of breath with lower extremity oedema at the initial surgica
Autor:
Rongjun Guo, Asher Chanan-Khan, Abhisek Swaika, Kena C. Miller, Kelvin P. Lee, Edward Spangenthal, Aneel Paulus, Kurt VonFricken
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 29(3)
Publikováno v:
American Journal of Clinical Oncology: Cancer Clinical Trials. 23:34-36
In the setting of interleukin-2 (IL-2) administration, tachycardias of ventricular origin are classified as serious, grade IV toxicities, necessitating the discontinuation of therapy. In this report, we describe a patient with renal cell carcinoma wh
Publikováno v:
Anticancer research. 27(5B)
Hypertension (HT) is a common complication of anti-angiogenic therapy. Its incidence, treatment and complications are undefined.Retrospective review of patients treated with bevacizumab (BV) from 2003-5. Common toxicity criteria (CTC) for adverse eve
Publikováno v:
Leukemialymphoma. 26(3-4)
Deoxyadenosines are closely related to adenosine and as such, may interfere with the cardiac adenylate cyclase pathway resulting in cardiac dysfunction. We report a rare case of a 42 year old man who developed transient cardiac failure following trea